Just trying to get a ballpark understanding of the revenue potentially generated from the handful of pre-sales agreements that have been announced.
"ICC expects to produce 1.2 million 30 millilitre bottles of BIDIOL annually. BIDIOL will be
made under the highest quality standards, supervised by the Ministry of Health in Uruguay.
BIDIOL is expected to
contain 16.7 mg of CBD per millilitre suspended in ecologic extra virgin olive oil. BIDIOL is expected to contain no THC, putting BIDIOL into a very select class as one of the world’s highest content CBD pharmaceutical grade oils." - Marketwired Oct.19, 2017
SOURCE: https://www.cannabiscare.ca/products/cbd-tincture-550-mg-30-ml/
I happened to find CBD oil for sale with the same volume (30ml) and CBD (16.7mg) in each bottle so can safely say each bottle of BIDIOL produced has a retail value of
$70 CAD.
Brasliv has agreed to purchase a minimum of 180,000 bottles.
Grupo Fenix has agreed to purchase 10% (120,000 bottles) of CBD produced in 2018.
Emblem Corp has agreed to purchase 10% (120,000 bottles) of CBD produced in 2018.
Total BIDIOL sold for 2018
420,000 bottles.
420,000 x $70 =
$29,400,000 CAD The pre-sale agreements in place with Brasliv, Grupo Fenix and Emblem Corp have a
Canadian retail value of
$29,400.000 CAD.
One thing to note is that only one of the three agreements are with a Canadian retailer. Pricing will vary drastically between South American and North American markets but also keep in mind that it is 5-6 times cheaper to produce CBD concentrates in Uruguay and that ICC is projecting ~75% profit margins.
*A pre-sale agreement with Avanti for the purchase of 150kg of CBD was excluded from this equation due to the fact that the type of CBD (oil, crystal, etc.) wasn't disclosed.